| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.0M | +296.9% |
| SG&A Expense | $7.3M | +46.7% |
| Operating Income | -$15.3M | -119.2% |
| Interest Expense | $979 | -98.8% |
| Pre-tax Income | -$26.8M | -94.3% |
| Income Tax | $0 | — |
| Net Income | -$26.8M | -94.3% |
| EPS (Basic) | -$1.73 | +43.5% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.0M | -28.3% |
| Accounts Receivable | $24K | +91.7% |
| Current Assets | $42.3M | -26.7% |
| Total Assets | $42.6M | -26.6% |
| Current Liabilities | $941K | +69.0% |
| Stockholders' Equity | $10.3M | -62.7% |
| Line Item | 2022-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.5M | -61.1% |
| Financing Cash Flow | -$3.7M | -105.8% |